INS and Hyperglycemia: The resultant need for exogenous insulin therapy to control clinical signs and to avoid diabetic complications and death [29] after the resolution of insulin-resistance causes is often attributable to glucotoxicity [1,11,14], a phenomenon associated with beta-cell death after chronic exposure to hyperglycemia [34,35].